Reference
Gonzalez-Rodriguez AP, et al. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT. Bone Marrow Transplantation 55: 461-463, No. 2, Feb 2020. Available from: URL: http://doi.org/10.1038/s41409-019-0525-1
Rights and permissions
About this article
Cite this article
Daratumumab. Reactions Weekly 1793, 156 (2020). https://doi.org/10.1007/s40278-020-75498-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-75498-6